Deal 2: Lupin snaps up Temmler's products
This article was originally published in Scrip
Executive Summary
Lupin has announced its second acquisition on the trot – this time an asset purchase deal concerning Temmler Pharma GmbH & Co's specialty product portfolio in Germany.